Search

Search Constraints

You searched for: Author/Creator Spelman, Timothy

Search Results

1. 2180. Incidence and Outcomes of Ventilator-Associated Events, Utilising Centre for Disease Control Criteria in a Tertiary Intensive Care Unit, Victoria, Australia. (26th November 2018)

2. [18F]FDG-PET-CT compared with CT for persistent or recurrent neutropenic fever in high-risk patients (PIPPIN): a multicentre, open-label, phase 3, randomised, controlled trial. Issue 8 (August 2022)

3. Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing–remitting multiple sclerosis. (August 2015)

4. Comparative efficacy of switching to natalizumab in active multiple sclerosis. (27th February 2015)

5. Greater sensitivity to multiple sclerosis disability worsening and progression events using a roving versus a fixed reference value in a prospective cohort study. (June 2018)

7. Patient‐reported outcomes of the Treatment and Prevention Study: A real‐world community‐based trial of direct‐acting antivirals for hepatitis C among people who inject drugs. Issue 7 (3rd May 2021)

8. The Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: results from the MSBase Registry. Issue 3 (28th December 2011)

9. Validation of novel point‐of‐care test for alanine aminotransferase measurement: A pilot cohort study. Issue 4 (10th October 2022)

10. Validation of novel point‐of‐care test for alanine aminotransferase measurement: A pilot cohort study. Issue 4 (10th October 2022)